Brind.
  1. Harrow forecasts growth exceeding the industry average in the pharmaceuticals sector.

Harrow's model is noted to mirror successful rollups seen in companies like Horizon Pharmaceuticals.

1 report, 1 independent Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Harrow's model is noted to mirror successful rollups seen in companies like Horizon Pharmaceuticals.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Insider MonkeyHarrow, Inc. (HROW): A Bull Case Theory We came across a bullish thesis on Harrow, Inc. on 1035 Capital Management’s Substack. In this article, we will summarize the bulls’ thesis on HROW. Harrow, In